Health
Pfizer says BNT162b2 vaccine is effective against new Covid strains – Pharmaceutical Business Review
Pfizer said that BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus.
Pfizer and BioNTech said that their Covid-19 vaccine BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus as per the results from an in vitro study.
The in vitro study, which was held by Pfizer and the University of Texas Medical Branch (UTMB), demonstrated that the antibodies from people subjected to the vaccine could effectively work against the rapidly spreading variants.
Reported initially in the UK and South Africa,…
-
General22 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
General17 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Noosa News21 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Business20 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?